The matrix metalloproteinases (MMPS) in the decidua and fetal membranes

Frontiers in Bioscience

Volumn 12, Issue 2, 2007, Pages 649-659

  Weiss, Amir ^a   Goldman, Shlomit ^a   Shalev, Eliezer ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Decidua; Enzyme; Extracellular matrix; Fetal membrane; Labor; Mattrix metalloprotease; MMP; Review; TIMP; Tissue inhibitor of matrix metalloprotease

Indexed keywords

EID: 34249854416     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2089     Document Type: Article

References (53)

1. Parry S. & J.F. Strauss III: Premature rupture of the fetal membranes. N Engl J Med 338, 663-670 (1998)
2. Bryant-Greenwood G.D: The extarcellular matrix of the human fetal membranes: structure and function. Placenta 19, 1-11(1998)
3. Handwerger S., E. Markoff & R. Richards: Regulation of the synthesis and release of decidual prolactin by placenta! and autocrine/paracrine factors. Placenta 12, 121-130 (1991)
4. Lee M.H. & G. Murphy: Matrix metalloproteinases at a glance. J Cell Sei 117, 4015-4016 (2004)
5. Bode W., C. Fernandez-Catalan, H. Tschesche, F. Grams, H. Nagase & K. Maskos: Structural properties of matrix metalloproteinases. Cell Mol Life Sci 55, 639-652 (1999)
6. Birkedal-Hansen H., W.G. Moor, M.K. Bodden, L.J. Windsor, B. Birkedal-Handen, A. Decarlo & J.A. Engler: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med4, 197-250(1993)
7. Fortunate S.J., R. Menon & S.J. Lombardi: Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes. Obstet Gynecol 94, 435-440 (1999)
8. Nagase H. & J.F. Woessner: Matrix metalloproteinases. J Biol Chem 274, 21491-21494 (1999)
9. Chakraborti S., M. Mandai, S. Das, A. Mandai & T. Chakraborti: Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253, 269-285 (2003)
10. Baker A.H., D.R. Edwards & G. Murphy: Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115, 3719-3727 (2002)
11. Sato H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E.Yamamoto & M. Seiki: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65(1994)
12. Vadillo-Ortega F., G. Gonzales-Avila, E.E. Furth, H. Lei, R.J. Muschel, W.O. Stetler-Stevenson & J.F. Strauss 3rd: 92-kd type IV collagenase (matrix metalloproteinase9) activity in human amniochorion increases with labor. Am J Pathol 46, 148-156 (1995)
13. 2a and indomethacin. Mol Hum Reprodl, 1187-1193 (2001)
14. Goldman S., A. Weiss, V. Eyali & E. Shalev: Differential activity of the gelatinases (matrix metalloproteinases 2 and 9) in the fetal mmembranes and decidua, associated with labour. Mol Hum Reprod 9,367-373 (2003).
15. Tsatas D., M.S. Baker & O.E. Rice: Differential expression of proteases in human gestational tissue before, during and after spontaneous-onset labour at term. J Reprod Fertil 116, 43-49 (1999)
16. Xu P., N. Alfaidy & J.R.G. Challis: Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 87, 1353-1361 (2002)
17. Bryant-Greenwood G.D. & S.Y. Yamamoto: Control of peripartal collagenolysis in the human chorio-decidua. Am J Obstet Gynecol 172, 63-70 (1995)
18. Maymon E., R. Romero, P. Pacora, M.T. Gervasi, S.S. Edwin, R. Gomez & D. Seubert: Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection. Am J Obstet Gynecol 182, 1545-1553 (2000)
19. Fortunate S.J., B. LaFleur & R. Menon: Collagenase-3 (MMP-13) in fetal membranes and amniotic fluid during pregnancy. Am J of Reprod Immunol 49, 120-125 (2003)
20. Fortunato S.J., R. Menon & S.J. Lombardi: Presence of four tissue inhibitors of matrix metalloproteinases (TIMPl,-2,-3 and-4) in human fetal membranes. Am J Reprod Immunol 40, 395-400 (1998)
21. Riley S.C., R. Leask, F.C. Denison, K. Wisely, A.A. Calder & D.C. Howe: Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes and placenta at parturition. J Endocrinol, 162, 351-359 (1999)
22. Maradny E.E, N. Kanayama, A. Halim, K. Maehara & T. Terao: Stretching of fetal membranes increases the concentration of interleukin-8 and collagenase activity. Am J Obstet Gynecol 174, 843-849 (1996)
23. Qin X., P.K. Chua, R.H. Ohira & G.D. BryantGreenwood: An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). Biol Reprod 56, 812820(1997)
24. McLaren J., D.J. Taylor & S.C. Bell: Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: implications for membrane remodeling and rupture. Am J Obstet Gynecol 182, 409-416 (2000)
25. Uchide K., H. Ueno, M. Inoue, A. Sakai, N. Fujimoto & Y. Okada: Matrix metalloproteinase-9 and tensile strength of fetal membranes in uncomplicated labor. Obstet Gynecol 95, 851-855 (2000)
26. Li W., N. Alfaidy & J. R. G. Challis: Expression of extracellular matrix metalloproteinase inducer in human placenta and fetal membranes at term labor. J Clin Endocrinol Metab 89, 2897-2904 (2004)
27. 6 integrin in extraplacental fetal membranes: possible role in human parturition. Mol Hum Reprod 10, 173-179 (2004)
28. Vadillo-Ortega F., G. Estrada-Gutiérrez: Role of matrix metalloproteinases in preterm labour. BJOG 112, 19-22 (2005)
29. McGregor JA., J.I. French, D. Lawellin, A. FrancoBuff, C. Smith & J.K. Todd: Bacterial protease-induced reduction of chorioamniotic membrane strength and elasticity. Obstet Gynecol 69, 167-174 (1987)
30. Vadillo-Ortega F., A. Hernandez, G. Gonzalea-Avila, L. Bermejo, K. Iwata & J.F. Strauss 3rd: Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinase-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 174, 1371 -1376 ( 1996)
31. Fortunate S.J., R. Menon & S.J. Lombardi: Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic mambrane. Am J Obstet Gynecol 177, 731-741(1997)
32. Fortunato S.J., R. Menon & S.J. Lombardi: MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J Perinat Medll, 362-368 (1999)
33. Maymon E., R.Romero, P. Pacora, M.T. Gervasi, S.S. Edwin, R. Gomez & D.E. Seubert: Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection Am J Obstet Gynecol 182, 1545-1551 (2000)
34. Angus S.R., S.Y. Segel, CD. Hsu, G.J. Locksmith, P. Clark, M.D. Sammel, G.A. Macones, J. F Strauss III & S. Parry: Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic infection. Am J Obstet Gynecol 185, 1232-1238(2001)
35. Fortunato S.J., R. Menon & S.J. Lombardi: Amniochorion gelatinase-gelatinase inhibitor imbalance in vitro: a possible infectious pathway to rupture. Obstet Gynecol 95, 240-244 (2000)
36. Fortunate S.J. & R. Menon: Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes. Am J Obstet Gynecol 184, 1399-1405 (2001)
37. Arechavaleta-Velasco F., D. Ogando, S. Parry & F. Vadillo-Ortega: Production of matrix metalloproteinase-9 in lypopolysaccharide-stimulated human amnion occurs through an autocrine and paracrine proinflammatory cytokine-dependant system. Biol Reprod 67, 1952-1958 (2002)
38. Arechavaleta-Velasco F., J. Mayon-Gonzales, M. Gonzalez-Jimenez, C. Hernandez-Guerrero & F. VadilloOrtega: Association of type II apoptosis and 92-kDa type IV collagenase expression in human amniochorion in prematurely ruptured membranes with tumor necrosis factor receptor-1 expression. J Soc Gynecol Investig 9, 60-67 (2002)
39. Edwin, S.S., R. Romero, C.M. Rathnasabapathy, N. Athayde, D.R. Armant & M.G. Subramanian: Protein kinase C stimulates release of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human decidual cell. J Matern Fetal Neonatal Med 12, 231-236 (2002)
40. Park, K.H., T. Chaiworapongsa, Y.M. Kim, J. Espinoza, J. Yoshimatsu, S. Edwin, R. Gomez, B. H. Yoon & R. Romero: Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med 31, 12-22 (2003)
41. Maymon E., R. Romero, P. Pacora, M.T. Gervasi, K. Bianco, F. Ghezzi & B. H. Yoon: Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. Am J Obstet Gynecol 183, 914-920 (2000)
42. Mackenzie A.P., F. Schatz, G. Krikum, E.F. Funai, S. Kadner and C.J. Lockwood: Mechanisms of abruptioninduced premature rupture of the fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1 ) expression. Am J Obstet Gynecol 191, 1996-2001 (2004)
43. Fujimoto T., S. Parry, M. Urbanek, M. Sammel, G. Macones, H. Kuivaniemi, R. Romero & J.F. Strauss III: A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of fetal membranes. J Biol Chem 227, 6296-6302 (2002)
44. Ferrand P.E., S. Parry, M. Sammel, G.A. Macones, H. Kuivaniemi, R. Romero & J. F. Strauss III: A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 8, 494-501(2002)
45. Fortunate S.J., S.J. Lombardi & R. Menon: Racial disparity in membrane response to infectious stimuli: a possible explanation for observed differences in the incidence of prematurity. Am J Obstet Gynecol 190, 1557-1563(2004)
46. Zuckerman H., E. Shalev, G. Gilad, E. Katzuni: Further study of the inhibition of premature labor by indomethacin. Part 1. J Perinea Med 12, 19-23 (1984)
47. Buhimschi T.A., W.B. Kramer, C.S. Buhimschi, L.P. Thompson & C.P. Weiner: Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. Am J Obstet Gynecol 182, 458-464 (2000)
48. Weiss A., S. Goldman, I. Ben Shlomo, V. Eyali, S, Leibovitz & E. Shalev: Mechanisms of matrix metalloproteinase-9 and matrix metalloproteinase-2 inhibition by N-acetylcysteine in the human term decidua and fetal membranes. Am J Ostet Gynecol 189, 1758-1763 (2003)
49. Lappas M., M. Permezel & G.E. Rice: W-AcetylCysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-KB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88,1723-1729(2003)
50. Meis P.J., M. Klebanoff, E. Thorn, M.P. Dombrowski, B. Sibai, A.H. Moawad, C.Y. Spong, J.C. Hauth, M. Miodovnic, M.W. Varner, K.J. Leveno, S.N. Caritis, J.D. lams, R.J. Wapner, D. Conway, M.J. O'Sullivan, M. Carpenter, B. Mercer, S.M. Ramin, J.M. Thorp, A.M. Peaceman & S. Gabbe: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 12, 2379-2385 (2003)
51. da Fonseca E.B., R.E. Bitter, M.H. Carvalho & M. Zugaib: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188, 419-424 (2003)
52. Oger S., C. Méhats, E. Dallot, D. Cabrol & M. J. Leroy: Evidence for a role of phosphodiesterase 4 in lipopolysaccharide-stimulated prostaglandin £2 production and matrix metalloproteinase-9 activity in human amniochorionic membranes. J Immunol 174, 8082-8089 (2005).
53. Goldman S & E. Shalev: Role of the matrix metalloproteinases, in human endometrial and ovarian cycles. Euro J Obstet Gynecol Reprod Biol 111, 109-121 (2003).